Educating Hairstylists on Melanoma and Skin Lesion Detection
Hairstylists are able to screen the scalp and neck of a large portion of the general public, making them useful for detecting abnormal skin lesions.
Hairstylists are able to screen the scalp and neck of a large portion of the general public, making them useful for detecting abnormal skin lesions.
Patients with desmoplastic melanoma have a high level of objective tumor response to treatment with antibodies to block programmed cell death 1 (PD-1) or PD-1 ligand (PD-L1).
The findings may have implications for cancer prevention.
The FDA accepted a New Drug Application to support the combination of the MEK inhibitor, binimetinib, and the BRAF inhibitor, encorafenib, for treating patients with BRAF-mutated unresectable or metastatic melanoma.
Hydrochlorothiazide use is associated with an increased risk of non-melanoma skin cancer, with evidence of a dose-response relationship.
Fluorouracil application can reduce the risk of surgery for squamous cell carcinoma for 1 year among patients with a history of keratinocyte carcinomas.
Laser monotherapy improves health-related quality of life in female patients with radiation-induced breast telangiectasias.
Pembrolizumab leads to a durable complete response with low rates of relapse — even 2 years after discontinuation — and may cure a subset of patients with metastatic melanoma.
The FDA has approved an adjuvant treatment for patients with melanoma with lymph node involvement or metastatic disease who have undergone complete resection.
Researchers advise dermatologists to discuss the importance of skin examinations and sunscreen use with patients with atopic dermatitis, who are an an increased risk of squamous cell carcinoma.